Key facts
- This page summarizes Fu Xi-Yong's Form 3 filing for NovaBridge Biosciences (NBP).
- 0 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 18 Mar 2026, 21:44.
Fu Xi-Yong - 18 Mar 2026 Form 3 Insider Report for NovaBridge Biosciences (NBP)
- Reporting relationship
- Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney, Director
- Issuer ticker
- NBP
- Reported as of
- 18 Mar 2026
- Net transaction value
- $0
- Reporting owner signature
- /s/ Xi-Yong (Sean) Fu
Source evidence
Original filing metadata and source links for verification.
3 source fields
Reporting owner
1 detail
Key filing fact
Fu Xi-Yong filed Form 3 for NovaBridge Biosciences (NBP) on 18 Mar 2026.
Change
- No earlier filing in this sequence is available for direct comparison.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reporting Owners (1)
CIK 0002088625
Primary reporting owner
Fu Xi-Yong
- Relationship
- Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney, Director
- Address
- C/O NOVABRIDGE BIOSCIENCES,, 2440 RESEARCH BOULEVARD, SUITE 400, ROCKVILLE
- Signature
- /s/ Xi-Yong (Sean) Fu
- Signature date
- 18 Mar 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
NBP
holding
Ordinary Shares
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 59,823
- Date
- 18 Mar 2026
- Ownership
- Direct
- Footnotes
- F1, F2
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
NBP
holding
Derivative
2025 Employee Share Option (right to buy)
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,245,000
- Exercise price
- $1.07
- Footnotes
- F1, F3, F4
NBP
holding
Derivative
Restricted Share Units
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- Date
- 18 Mar 2026
- Ownership
- Direct
- Underlying class
- Ordinary Shares
- Underlying amount
- 1,245,000
- Exercise price
- Footnotes
- F1, F3, F5
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 5 footnotes
Footnote F1
The Ordinary Shares may be represented by American Depositary Shares ("ADS"). Each 10 ADSs represent 23 Ordinary Shares of the Issuer.
Footnote F2
Reported securities are represented by 26,010 ADSs.
Footnote F3
Number of underlying securities and exercise price expressed in terms of ADSs.
Footnote F4
The option was granted on November 1, 2024. The option vests and becomes exercisable in four equal annual installments beginning on the first anniversary of the grant date.
Footnote F5
Each restricted share unit ("RSU") represents a contingent right to receive one ADS. The RSUs vest, if at all, in four separate installments upon the Issuer's ADS's achieving certain specified prices per share. The RSUs have no expiration date.
SEC remarks
Chief Executive Officer and Director Exhibit List: Ex. 24.1 - Power of Attorney